Metrics as of 10/14/2026, 04:09 PM (Berlin time), refresh in progress.
Myomo Stock
Myomo, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Paul R. Gudonis
- Employees
- 195
- Market cap
- $48 M
- IPO
- 12/06/2017
Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals…
Myomo stock: price history
1D
-7.7%
1W
-16.1%
1M
-7.0%
6M
+39.7%
YTD
+31.9%
1Y
+11.1%
2Y
-69.6%
5Y
-91.0%
10Y
–
Next earnings date
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~51% stronger price swings than usual
Ask the agents about Myomo
Analyst assessment of Myomo
PRICE TARGET LOW
US$1.10
CONSENSUS
US$3.45
MEDIAN
US$3.50
PRICE TARGET HIGH
US$5.75
0
STRONG BUY
7
BUY
1
HOLD
0
SELL
0
STRONG SELL
8
TOTAL · Buy
As of: 27/08/2026
Myomo stock metrics
P/E
-3.53
P/B
8.79
EV/EBITDA
-5.56
RETURN ON EQUITY
-69.0%
NET MARGIN
-34.4%
DEBT/EQUITY
3.44
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
89.9%
FLOAT SHARES
35,621,999
AVG. DAILY VOLUME (30D)
334,453
Insider transactions (SEC)
HENRY DAVID A
GUDONIS PAUL R
Kovelman Harry
HENRY DAVID A
GUDONIS PAUL R
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Myomo stock
What does Myomo do?
Myomo, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Paul R. Gudonis, the company employs around 195 people.
The IPO was on 12/06/2017; the stock trades on AMEX under the ticker MYO.
What do analysts say about Myomo stock?
8 analysts rate the stock, the consensus is Buy (as of 27/08/2026).
The average price target is US$3.45, ranging from US$1.10 to US$5.75, with a median of US$3.50.
This is an external assessment, not a statement by Market Jury.
When does Myomo report next?
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly 51% stronger than usual.
Does Myomo pay a dividend?
No, Myomo currently does not pay a dividend.
Which stocks are comparable to Myomo?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Myomo stock analyzed?
Clicking "Analyze stock" lets five strategies assess Myomo against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.